Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2020 Jun;189(6):1127-1135.
doi: 10.1111/bjh.16487. Epub 2020 Jan 30.

The prevalence and significance of monoclonal gammopathy of undetermined significance in acute medical admissions

Affiliations
Clinical Trial

The prevalence and significance of monoclonal gammopathy of undetermined significance in acute medical admissions

Catherine Atkin et al. Br J Haematol. 2020 Jun.

Abstract

Monoclonal gammopathy of undetermined significance (MGUS) affects 3·2% of adults aged >50 years. MGUS carries a life-long risk of progression to multiple myeloma and causes complications including infection and renal impairment; common causes of hospital admission. This study aimed to assess MGUS prevalence in emergency medical hospital admissions. Patients were recruited from unselected emergency medical admissions in a hospital in the United Kingdom. Serum protein electrophoresis was performed, with immunofixation of abnormal results. Reason for admission and routine test results were recorded. After education about MGUS and myeloma, patients chose whether they wished to be informed of new diagnoses. A total of 660 patients were tested and 35 had a paraprotein suggestive of MGUS. The overall rate of MGUS was 5·3%. MGUS prevalence in those aged >50 years was 6·94%, higher than the previously published rate of 3·2% (P < 0·0005). There were higher rates in those with chronic kidney disease (13·75% vs. 4·14%, P = 0·002), heart failure (14% vs. 4·59%, P = 0·012), anaemia (8·96% vs. 3·41%, P = 0·003) or leucocytosis (9·33% vs. 3·04%, P = 0·002). In all, 96% of patients wished to be informed of their screening results. The prevalence of MGUS in emergency hospital admissions is higher than expected based on previous population-based rates. This may suggest a selected population for screening.

Keywords: acute medicine; infection; monoclonal gammopathy of undetermined significance; renal dysfunction; screening.

PubMed Disclaimer

Comment in

References

    1. Anagnostopoulos, A., Evangelopoulou, A., Sotou, D., Gika, D., Mitsibounas, D. & Dimopoulos, M.-A. (2002) Incidence and evolution of monoclonal gammopathy of undetermined significance (MGUS) in Greece. Annals of Hematology, 81, 357-361.
    1. Atkin, C., Richter, A. & Sapey, E. (2018) What is the significance of monoclonal gammopathy of undetermined significance? Clinical Medicine (London), 18, 391-396.
    1. Bird, J., Behrens, J., Westin, J., Turesson, I., Drayson, M., Beetham, R., Dsa, S., Soutar, R., Waage, A., Gulbrandsen, N., Gregersen, H., Low, E. & Haemato-Oncology Task Force of the British Committee for Standards in Haematology, UK Myeloma Forum and Nordic Myeloma Study Group (2009) UK Myeloma Forum (UKMF) and Nordic Myeloma Study Group (NMSG): guidelines for the investigation of newly detected M-proteins and the management of monoclonal gammopathy of undetermined significance (MGUS). British Journal of Haematology, 147, 22-42.
    1. Bird, J., Owen, R., D'sa, S., Snowden, J., Ashcroft, J., Yong, K., Cook, G., Feyler, S., Davies, F., Morgan, G., Cavenagh, J., Low, E., Behrens, J., Jenner, M.,Pratt, G. & Haemato-oncology Task Force of British Committee for Standards in Haematology (BCSH) and UK Myeloma Forum (2014). Guidelines for the diagnosis and management of multiple myeloma 2014. British Journal of Haematology, 154, 32-75.
    1. Bladé, J. & Kyle, R.A. (1999) Nonsecretory myeloma, immunoglobulin D myeloma, and plasma cell leukemia. Hematology/Oncology Clinics of North America, 13, 1259-1272.

Publication types

LinkOut - more resources